Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions Journal Article


Authors: Pan, Y. X.; Xu, J.; Xu, M.; Rossi, G. C.; Matulonis, J.; Pasternak, G. W.
Article Title: Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions
Abstract: Heroin remains a major drug of abuse and is preferred by addicts over morphine. Like morphine, heroin has high affinity and selectivity for -receptors, but its residual analgesia in exon 1 MOR-1 knockout mice that do not respond to morphine suggests a different mechanism of action. MOR-1 splice variants lacking exon 1 have been observed in mice, humans, and rats, raising the possibility that they might be responsible for the residual heroin and morphine-6/3-glucuronide (M6G) analgesia in the exon 1 knockout mice. To test this possibility, we disrupted exon 11 of MOR-1, which eliminates all of the variants that do not contain exon 1. Morphine and methadone analgesia in the exon 11 knockout mouse was normal, but the analgesic actions of heroin, M6G, and fentanyl were markedly diminished in the radiant heat tail- flick and hot-plate assays. Similarly, the ability of M6G to inhibit gastrointestinal transit was greatly diminished in these exon 11 knockout mice, whereas the ability of morphine was unchanged. These findings identify receptors selectively involved with heroin and M6G actions and confirm the relevance of the exon 11- associated variants and raise important issues regarding the importance of atypical truncated G-protein-coupled receptors.
Keywords: controlled study; unclassified drug; exon; genetics; mutation; exons; nonhuman; drug megadose; mouse; animal; mouse mutant; animals; mice; mice, knockout; gene targeting; mus; drug inhibition; animal experiment; genetic variability; drug effect; heterozygote; drug mechanism; gene disruption; rat; alternative splicing; alternative rna splicing; drug derivative; rattus; methadone; morphine; analgesia; g protein coupled receptor; mu opiate receptor; receptors, opioid, mu; knockout mouse; tail flick test; naloxone; fentanyl; knockout; opiate receptor; 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide; beta funaltrexamine; diamorphine; enkephalin[2,5 dextro penicillamine]; morphine 6 acetate; morphine 6 glucuronide; mu 1 opiate receptor; naltrindole; beta-funaltrexamine; naltrexone; oprm protein, mouse; analgesic activity; exon 11; gastrointestinal transit; hot plate test; thermoregulation; heroin
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 106
Issue: 12
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2009-03-24
Start Page: 4917
End Page: 4922
Language: English
DOI: 10.1073/pnas.0811586106
PUBMED: 19273844
PROVIDER: scopus
PMCID: PMC2660730
DOI/URL:
Notes: --- - "Cited By (since 1996): 5" - "Export Date: 30 November 2010" - "CODEN: PNASA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yingxian Pan
    132 Pan
  2. Gavril W Pasternak
    414 Pasternak
  3. Ming Ming Xu
    34 Xu
  4. Jin   Xu
    60 Xu